GHOSH ANIRVAN (Chief Executive Officer) sold 0.7% of their position (581.00 shares) of UNITY BIOTECHNOLOGY, INC. on the open market
Open‑market sale worth $1.7K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/3/2023ACC: 0000950170-23-037992
DirectorOfficer· Chief Executive Officer
Since Mar 2020
-581.00
Net shares
Net seller
$1.7K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
581.00 disposed
Non-Derivative Transactions1
Common Stock, $0.0001 par value
Direct
Shares
−581.00
Price / share
$2.94
Trade value
$1.71K
% of position
0.7%
8/2/2023
84.05K→83.47K
Total
Net shares
−581.00
Net value
-$1.71K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 par value Direct | 8/2/2023 | S · Sale | −581.00 | $2.94 | $1.71K | 0.7% | 84.05K | 83.47K |
| Total | −581.00 | -$1.71K | ||||||
Derivative Transactions0
No derivative transactions reported